Clinical Trials
3 trialsNCT04648189 2023-10-19
Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLC
The Netherlands Cancer Institute
Phase 2 Withdrawn
NCT02621190 2016-08-17
CARVE
Erasmus Medical Center
Phase 2 Withdrawn
NCT02065323 2015-01-19
A Study of Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT
Comprehensive Cancer Centers of Nevada
Phase 2 Withdrawn